Development and initial testing of the stroke rapid-treatment readiness tool

J Neurosci Nurs. 2014 Oct;46(5):267-73. doi: 10.1097/JNN.0000000000000082.


No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cerebral Infarction / nursing*
  • Cerebral Infarction / therapy
  • Early Medical Intervention / organization & administration*
  • Efficiency, Organizational
  • Guideline Adherence*
  • Humans
  • Infusions, Intravenous
  • Patient Admission
  • Patient Care Team / organization & administration
  • Quality Improvement
  • Thrombolytic Therapy / nursing*
  • Time and Motion Studies
  • Tissue Plasminogen Activator / administration & dosage*
  • Workflow


  • Tissue Plasminogen Activator